Aura Biosciences, Inc. (AURA) Misses Q2 EPS by 7c

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• Paychex (PAYX) call put ratio 1 call 1.3 puts as share price down 7.3%
• Zenta Group clarifies share count after ZentoAI acquisition